Elongation factor 2 as a target for selective inhibition of protein synthesis in vitro by the novel aromatic bisamidine

Mol Cell Biochem. 2002 Apr;233(1-2):159-64. doi: 10.1023/a:1015548131930.

Abstract

The effect of the novel aromatic bisamidine 1 on protein synthesis in cell-free translational system isolated from rat livers was studied. The bisamidine 1 caused inhibition of [14C]leucine incorporation into proteins proportionally to its concentration. To establish a precise mechanism of inhibition, we evaluated the effect of the bisamidine 1 on the isolated ribosomes and purified to homogeneity elongation factors. Preincubation of the bisamidine 1 with ribosomes resulted in partial inhibition of their activity in whole elongation system. The eucaryotic elongation factor 1 (eEF-1) was not significantly affected by the bisamidine 1. In contrast to eEF-1, the bisamidine 1 preincubated with the eucaryotic elongation factor 2 (eEF-2) caused total inhibition of its activity in the translocation process. The inhibitory effect of the bisamidine 1 on eEF-2 activity was confirmed in diphtheria toxin-dependent ADP-ribosylation reaction. The results suggest a high action specificity of the bisamidine 1 as potential anticancer drug, since the primary target seems to be highly conserved protein-elongation factor 2.

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell-Free System
  • Furans / pharmacology*
  • In Vitro Techniques
  • Leucine / metabolism
  • Microsomes, Liver / drug effects
  • Microsomes, Liver / metabolism
  • Peptide Elongation Factor 2 / antagonists & inhibitors*
  • Peptide Elongation Factor 2 / metabolism
  • Protein Synthesis Inhibitors / pharmacology*
  • Rats
  • Ribosomes / drug effects
  • Ribosomes / metabolism

Substances

  • Antineoplastic Agents
  • Furans
  • Peptide Elongation Factor 2
  • Protein Synthesis Inhibitors
  • bisamidine
  • Leucine